Inotropic agents are used for the treatment of patients with systolic heart failure with reduced left ventricular ejection fraction (HfrEF) to maintain hemodynamic stability .In some cases, these agents can be used until a definite or escalated supportive therapy is planned, which can include coronary revascularization or mechanical circulatory support. This article focuses on the use of various inotropes used for treating heart failures. Inotropic agents improve the contractility of the myocardium and can also affect the heart rate and peripheral vascular resistance.
Due to advancements in advanced heart failure therapies, including transplant and mechanical circulatory support, their use is becoming more common for other indications. The efficacy of acute intravenous inotropic support is well established in patients with severe myocardial systolic dysfunction. Inotropic agents like…
